Life Sciences
Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
July 23, 2019
$50M IRS Claim Holds Up Avadel Pharma Ch. 11 Confirmation
Attorneys for bankrupt drugmaker Avadel Specialty Pharmaceuticals LLC said Tuesday that a combined hearing on its Chapter 11 plan and disclosure statement would have to wait after the Internal Revenue Service filed a $50 million claim against the estate related to outstanding tax liabilities.
-
July 23, 2019
Corcept Wants Sun's Cushing's Syndrome Drug Blocked
Corcept Therapeutics Inc. has asked a New Jersey federal judge to block Sun Pharma's planned generic version of its flagship Cushing's syndrome medication Korlym, claiming three valid patents will be infringed.
-
July 22, 2019
Amgen, Allergan Launch 2 Biosimilars With Court's Blessing
Amgen and Allergan have started selling their biosimilar versions of Genentech's blockbuster cancer treatments Avastin and Herceptin in the U.S., announcing the launch immediately after a Delaware federal judge refused to block the sales.
-
July 22, 2019
Calif. Expert Says J&J's 'Propaganda' Misled Mesh Patients
A consumer behavior expert testified Monday that a "propaganda analysis" he conducted on hundreds of Johnson & Johnson marketing materials showed that they would have misled consumers by downplaying the risks of surgical mesh devices, during California's trial alleging the industry titan falsely marketed the mesh products.
-
July 22, 2019
DOJ Errors Doom Suboxone Film Fraud Case, Indivior Says
Indivior has urged a federal judge to toss an indictment accusing it of misrepresenting the risk of abuse posed to children by its opioid-dependence treatment Suboxone Film, claiming federal prosecutors included inadmissible references to a doctor's health care fraud convictions and possibly even intentionally misled the grand jury.
Areas of Coverage
- AGENCIES
- U.S. Consumer Product Safety Commission
- U.S. Food and Drug Administration
- U.S. Patent and Trademark Office
- U.S. International Trade Commission
- POLICY & REGULATION
- Affordable Care Act
- Federal Food, Drug, and Cosmetic Act
- Antitrust and consumer protection controls
- Drug and medical device lobbying
- State and international life sciences legislation and regulation
- ENFORCEMENT
- Drug and medical device recalls
- Drug safety actions
- Pay-for-delay investigations
- Merger reviews
- LITIGATION
- Patent disputes, including
- Abbreviated New Drug Application litigation
- Section 301 cases
- Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
- Consumer litigation and class actions
- Fraud and compliance suits
- Antitrust disputes
- Labor and employment suits
- Shareholder and corporate governance disputes
- Bankruptcy proceedings
- TRANSACTIONS
- Mergers, acquisitions, and joint ventures
- Share buybacks and stock splits
- Private equity deals
- Patent-licensing agreements
- PROFILES
- Personnel moves
- Profiles of life sciences practice groups
Readership
- Life sciences lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the drug, biotechnology, and medical device industries
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals